(Q46961137)

English

Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer

scientific article published on 3 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

glucose monitoring

1 reference

based on heuristic

inferred from title

Andreas K. Buck

10

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

object named as

Rupert Langer

4

0 references

Markus Schwaiger

object named as

Markus Schwaiger

14

0 references

Hinrich A Wieder

6

object named as

Hinrich A Wieder

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

3

object named as

Tibor Schuster

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

5

object named as

Karen Becker

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

Jörg-Rüdiger Siewert

8

object named as

Jörg-Rüdiger Siewert

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

Christian Meyer zum Büschenfelde

9

object named as

Christian Meyer zum Büschenfelde

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

12

object named as

Matthias P A Ebert

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

Christian Peschel

13

object named as

Christian Peschel

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

author name string

Katja Ott

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

Ken Herrmann

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

Hans-Jürgen Wester

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

Dirk Wilhelm

11

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

Florian Lordick

15

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

Bernd Joachim Krause

16

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

publication date

3 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

18

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

12

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

3316-3323

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

https://scigraph.springernature.com/pub.10.1245/s10434-011-1743-y

0 references

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Regulation of de novo and salvage pathways in chemotherapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

2-[11C]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Surgical resection for cancer of the cardia

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Usefulness of preoperative FDG-PET for detection of gastric cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1743-Y

21 January 2018

Identifiers

10.1245/S10434-011-1743-Y

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/21537865

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46961137&oldid=2139739792"